意大利竞技体育资格指南(COCIS): 2023年更新版心律失常运动员评估的新适应症是什么?

IF 1.2 4区 医学 Q3 SPORT SCIENCES
Luigi Sciarra, Antonio Scarà, Alessandro Biffi, Silvia Castelletti, Domenico Corrado, Antonio Dello Russo, Franco Giada, Giuseppe Inama, Loira Leoni, Viviana Maestrini, Zefferino Palamà, Peter Schwartz, Andrea Spampinato, Paolo Zeppilli, Alessandro Zorzi, Pietro Delise
{"title":"意大利竞技体育资格指南(COCIS): 2023年更新版心律失常运动员评估的新适应症是什么?","authors":"Luigi Sciarra, Antonio Scarà, Alessandro Biffi, Silvia Castelletti, Domenico Corrado, Antonio Dello Russo, Franco Giada, Giuseppe Inama, Loira Leoni, Viviana Maestrini, Zefferino Palamà, Peter Schwartz, Andrea Spampinato, Paolo Zeppilli, Alessandro Zorzi, Pietro Delise","doi":"10.23736/S0022-4707.25.16910-7","DOIUrl":null,"url":null,"abstract":"<p><p>The COCIS 2023 guidelines represent the latest update on competitive sports eligibility for athletes with heart disease, developed by the Italian Society of Sports Cardiology and associated medical societies. These updated guidelines reflect advancements in cardiology and sports medicine and introduce clear class of recommendations and levels of evidence for assessing athletes with heart disease. This document focuses on the differences between the 2023 and 2017 versions, particularly regarding athletes with arrhythmias. The guidelines integrate new scientific evidence, including modifications to criteria for specific arrhythmic conditions like Wolf-Parkinson-White (WPW) Syndrome, Brugada Syndrome, long QT syndrome (LQTS), and premature ventricular beats (PVBs). Updates on the return-to-play timing after successful catheter ablation are also included. Key updates include the revised arrhythmic risk thresholds for WPW syndrome; these guidelines also expand recommendations for asymptomatic pre-excitation cases. In Brugada Syndrome, eligibility remains dependent on the presence of malignant arrhythmias and genetic risk factors, with scoring systems to aid risk stratification. For LQTS, eligibility is reconsidered for asymptomatic individuals with a negative phenotype and a positive genotype, with beta-blocker use. Additionally, the management of PVBs is refined, with new criteria for further investigation and risk assessment. COCIS 2023 introduces a more nuanced, evidence-based approach to the eligibility of athletes with arrhythmias. The guidelines provide clinicians with detailed recommendations for managing a variety of arrhythmic conditions. As scientific research advances, these guidelines will continue to evolve, ensuring safe athletic participation for individuals with cardiovascular conditions.</p>","PeriodicalId":17013,"journal":{"name":"Journal of Sports Medicine and Physical Fitness","volume":" ","pages":"826-833"},"PeriodicalIF":1.2000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Italian guidelines for competitive sport eligibility (COCIS): what are the new indications in the updated 2023 version for the evaluation of athletes with arrhythmias?\",\"authors\":\"Luigi Sciarra, Antonio Scarà, Alessandro Biffi, Silvia Castelletti, Domenico Corrado, Antonio Dello Russo, Franco Giada, Giuseppe Inama, Loira Leoni, Viviana Maestrini, Zefferino Palamà, Peter Schwartz, Andrea Spampinato, Paolo Zeppilli, Alessandro Zorzi, Pietro Delise\",\"doi\":\"10.23736/S0022-4707.25.16910-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The COCIS 2023 guidelines represent the latest update on competitive sports eligibility for athletes with heart disease, developed by the Italian Society of Sports Cardiology and associated medical societies. These updated guidelines reflect advancements in cardiology and sports medicine and introduce clear class of recommendations and levels of evidence for assessing athletes with heart disease. This document focuses on the differences between the 2023 and 2017 versions, particularly regarding athletes with arrhythmias. The guidelines integrate new scientific evidence, including modifications to criteria for specific arrhythmic conditions like Wolf-Parkinson-White (WPW) Syndrome, Brugada Syndrome, long QT syndrome (LQTS), and premature ventricular beats (PVBs). Updates on the return-to-play timing after successful catheter ablation are also included. Key updates include the revised arrhythmic risk thresholds for WPW syndrome; these guidelines also expand recommendations for asymptomatic pre-excitation cases. In Brugada Syndrome, eligibility remains dependent on the presence of malignant arrhythmias and genetic risk factors, with scoring systems to aid risk stratification. For LQTS, eligibility is reconsidered for asymptomatic individuals with a negative phenotype and a positive genotype, with beta-blocker use. Additionally, the management of PVBs is refined, with new criteria for further investigation and risk assessment. COCIS 2023 introduces a more nuanced, evidence-based approach to the eligibility of athletes with arrhythmias. The guidelines provide clinicians with detailed recommendations for managing a variety of arrhythmic conditions. As scientific research advances, these guidelines will continue to evolve, ensuring safe athletic participation for individuals with cardiovascular conditions.</p>\",\"PeriodicalId\":17013,\"journal\":{\"name\":\"Journal of Sports Medicine and Physical Fitness\",\"volume\":\" \",\"pages\":\"826-833\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Sports Medicine and Physical Fitness\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.23736/S0022-4707.25.16910-7\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/3/21 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"SPORT SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Sports Medicine and Physical Fitness","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.23736/S0022-4707.25.16910-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/21 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"SPORT SCIENCES","Score":null,"Total":0}
引用次数: 0

摘要

COCIS 2023指南是由意大利运动心脏病学会和相关医学学会制定的关于心脏病运动员竞技体育资格的最新更新。这些更新的指南反映了心脏病学和运动医学的进步,并为评估患有心脏病的运动员引入了明确的建议类别和证据水平。本文件侧重于2023年和2017年版本之间的差异,特别是关于心律失常运动员的差异。该指南整合了新的科学证据,包括修改特定心律失常条件的标准,如Wolf-Parkinson-White (WPW)综合征、Brugada综合征、长QT综合征(LQTS)和室性早搏(pbs)。还包括导管消融成功后恢复比赛时间的更新。主要更新包括修订WPW综合征的心律失常风险阈值;这些指南还扩大了对无症状预激病例的建议。在Brugada综合征中,是否有资格仍然取决于是否存在恶性心律失常和遗传风险因素,并使用评分系统来帮助进行风险分层。对于LQTS,对于无症状且表型阴性和基因型阳性的个体,重新考虑使用β受体阻滞剂的资格。此外,pvb的管理也得到了改进,有了进一步调查和风险评估的新标准。COCIS 2023引入了一种更细致、基于证据的方法来评估心律失常运动员的资格。该指南为临床医生提供了管理各种心律失常状况的详细建议。随着科学研究的进步,这些指导方针将继续发展,确保有心血管疾病的个人安全参加运动。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Italian guidelines for competitive sport eligibility (COCIS): what are the new indications in the updated 2023 version for the evaluation of athletes with arrhythmias?

The COCIS 2023 guidelines represent the latest update on competitive sports eligibility for athletes with heart disease, developed by the Italian Society of Sports Cardiology and associated medical societies. These updated guidelines reflect advancements in cardiology and sports medicine and introduce clear class of recommendations and levels of evidence for assessing athletes with heart disease. This document focuses on the differences between the 2023 and 2017 versions, particularly regarding athletes with arrhythmias. The guidelines integrate new scientific evidence, including modifications to criteria for specific arrhythmic conditions like Wolf-Parkinson-White (WPW) Syndrome, Brugada Syndrome, long QT syndrome (LQTS), and premature ventricular beats (PVBs). Updates on the return-to-play timing after successful catheter ablation are also included. Key updates include the revised arrhythmic risk thresholds for WPW syndrome; these guidelines also expand recommendations for asymptomatic pre-excitation cases. In Brugada Syndrome, eligibility remains dependent on the presence of malignant arrhythmias and genetic risk factors, with scoring systems to aid risk stratification. For LQTS, eligibility is reconsidered for asymptomatic individuals with a negative phenotype and a positive genotype, with beta-blocker use. Additionally, the management of PVBs is refined, with new criteria for further investigation and risk assessment. COCIS 2023 introduces a more nuanced, evidence-based approach to the eligibility of athletes with arrhythmias. The guidelines provide clinicians with detailed recommendations for managing a variety of arrhythmic conditions. As scientific research advances, these guidelines will continue to evolve, ensuring safe athletic participation for individuals with cardiovascular conditions.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.90
自引率
5.90%
发文量
393
审稿时长
6-12 weeks
期刊介绍: The Journal of Sports Medicine and Physical Fitness publishes scientific papers relating to the area of the applied physiology, preventive medicine, sports medicine and traumatology, sports psychology. Manuscripts may be submitted in the form of editorials, original articles, review articles, case reports, special articles, letters to the Editor and guidelines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信